SCHEMBL6205926

SCHEMBL6205926

O=C1c2ccc(Cl)cc2CC1(F)Br

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP1 P53582 2/20 0.41
PPOX P50336 1/20 0.39
SRD5A1 P18405 3/20 0.39
AHR P35869 2/20 0.39
S100A4 P26447 2/20 0.38
CES1 P23141 1/20 0.36
SRD5A2 P31213 2/20 0.36
DRD2 P14416 3/20 0.35
HTR2A P28223 3/20 0.35
HTR2C P28335 3/20 0.35
HTR2B P41595 1/20 0.35
SIGMAR1 Q99720 1/20 0.35
CMA1 P23946 1/20 0.35
HTR1A P08908 2/20 0.34
DRD4 P21917 2/20 0.34
HTR7 P34969 2/20 0.34
HTT P42858 1/20 0.34
TDP2 O95551 1/20 0.34
MAPT P10636 1/20 0.34
F7 P08709 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6204873 0.82 METAP1 (0.43) METAP1PPOXSRD5A1AHRS100A4
SCHEMBL6251847 0.79 METAP1 (0.41) METAP1PPOXSRD5A1AHRS100A4
SCHEMBL29237788 0.79 METAP1 (0.41) METAP1PPOXSRD5A1AHRS100A4
SCHEMBL29237727 0.76 METAP1 (0.38) METAP1PPOXSRD5A1AHRS100A4
SCHEMBL31030947 0.76 METAP1 (0.38) METAP1PPOXSRD5A1AHRS100A4
SCHEMBL29237729 0.76 METAP1 (0.38) METAP1PPOXSRD5A1AHRS100A4
SCHEMBL29448019 0.75 METAP1 (0.43) METAP1PPOXSRD5A1AHRS100A4
SCHEMBL14430319 0.75 METAP1 (0.43) METAP1PPOXSRD5A1AHRS100A4
SCHEMBL2902324 0.74 METAP1 (0.41) METAP1PPOXSRD5A1AHRS100A4
SCHEMBL28750465 0.74 L3MBTL1 (0.47) S100A4CES1HTR2AHTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1157014-B1 POLYCYCLIC 2-AMINO-DIHYDROTHIAZOLE SYSTEMS, METHOD FOR THE PRODUCTION THEREOF AND THEIR UTILIZATION AS MEDICAMENT AVENTIS PHARMA GMBH (DE) 2005-08-24 EP disclosed
EP-1098891-B1 POLYCYCLIC THIAZOLIDIN-2-YLIDENE AMINES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS AVENTIS PHARMA GMBH (DE) 2005-08-10 EP disclosed
EP-1157014-A1 POLYCYCLIC 2-AMINO-DIHYDROTHIAZOLE SYSTEMS, METHOD FOR THE PRODUCTION THEREOF AND THEIR UTILIZATION AS MEDICAMENT Aventis Pharma Deutschland GmbH (DE) 2001-11-28 EP disclosed
US-6235763-B1 THERAPY FOR EATING DISORDERS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2001-05-22 US disclosed
EP-1098891-A1 POLYCYCLIC THIAZOLIDIN-2-YLIDENE AMINES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS Aventis Pharma Deutschland GmbH (DE) 2001-05-16 EP disclosed
US-6159996-A Polycyclic thiazolidin-2-ylidene amines, process for their preparation, and their use as pharmaceuticals AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2000-12-12 US disclosed
WO-2000051994-A1 POLYCYCLIC 2-AMINO-DIHYDROTHIAZOLE SYSTEMS, METHOD FOR THE PRODUCTION THEREOF AND THEIR UTILIZATION AS MEDICAMENT AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2000-09-08 WO disclosed
WO-2000004006-A1 POLYCYCLIC THIAZOLIDIN-2-YLIDENE AMINES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2000-01-27 WO disclosed